Effect of PCSK9 Inhibitors on Systemic Immune Inflammation Index and Cardiovascular Risk in Patients with Ultra-High-Risk ASCVD Combined with CKD DOI

传敏 菅

Advances in Clinical Medicine, Journal Year: 2025, Volume and Issue: 15(03), P. 859 - 869

Published: Jan. 1, 2025

Language: Английский

Effect of PCSK9 Inhibitors on Systemic Immune Inflammation Index and Cardiovascular Risk in Patients with Ultra-High-Risk ASCVD Combined with CKD DOI

传敏 菅

Advances in Clinical Medicine, Journal Year: 2025, Volume and Issue: 15(03), P. 859 - 869

Published: Jan. 1, 2025

Language: Английский

Citations

0